Carter Boyd

Dr. Carter Boyd

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Urology
Verified
Journal Article
Closed access
ANAlexander P. Nocera
Alexander P. Nocera
CBCarter Boyd
Carter Boyd
HBHunter Boudreau
Hunter Boudreau
OHOrnin Hakim
Ornin Hakim
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami

1 November 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
CBCarter Boyd
Carter Boyd
DIDani C. Inglesby
Dani C. Inglesby
BCBritney Corey
Britney Corey
BGBenjamin J. Greene
Benjamin J. Greene
MHMichael A. Harrington
Michael A. Harrington
MTM. Lance Tavana
M. Lance Tavana

1 April 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
CMC. Haddon Mullins
C. Haddon Mullins
CBCarter Boyd
Carter Boyd
BCBritney L. Corey
Britney L. Corey

12 December 2019 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
PDF file
VWVictor T. Warren
Victor T. Warren
BPBhumika Patel
Bhumika Patel
CBCarter Boyd
Carter Boyd

1 December 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
CCChristine S. Collins
Christine S. Collins
NSNikhi Singh
Nikhi Singh
SAShivani Ananthasekar
Shivani Ananthasekar
CBCarter Boyd
Carter Boyd
EBEugene Brabston
Eugene Brabston
TKTimothy W. King
Timothy W. King

1 October 2018 in Asian Journal of Urology
Verified
Journal Article
Open access
CBCarter Boyd
Carter Boyd
KWKyle Wood
Kyle Wood
DWDustin Whitaker
Dustin Whitaker
DADean G. Assimos
Dean G. Assimos
The prevalence of kidney stone disease is increasing, afflicting 7%-11% of the United States population. Multiple systemic conditions, including obesity and diabetes, are also on the rise. Further, the literature has demonstrated a strong association between metabolic syndrome, its components, and kidney stone disease. In this article, we aim to review the associations of metabolic syndrome and nephrolithiasis, discussing the pathophysiology, urinary parameters, and clinical presentations. With this knowledge, urologists will have a more comprehensive understanding of this complex population of metabolic stone formers enabling improved patient management and treatment of stone disease.